Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The effects of canagliflozin on heart failure and cardiovascular death by baseline participant characteristics: Analysis of the CREDENCE trial.
Arnott C, Li JW, Cannon CP, de Zeeuw D, Neuen BL, Heerspink HJL, Charytan DM, Agarwal A, Huffman MD, Figtree GA, Bakris G, Chang TI, Feng K, Rosenthal N, Zinman B, Jardine MJ, Perkovic V, Neal B, Mahaffey KW. Arnott C, et al. Among authors: neuen bl. Diabetes Obes Metab. 2021 Jul;23(7):1652-1659. doi: 10.1111/dom.14386. Epub 2021 Apr 16. Diabetes Obes Metab. 2021. PMID: 33769679
Global kidney disease.
Neuen BL, Taylor GE, Demaio AR, Perkovic V. Neuen BL, et al. Lancet. 2013 Oct 12;382(9900):1243. doi: 10.1016/S0140-6736(13)62086-3. Lancet. 2013. PMID: 24120192 No abstract available.
Chronic kidney disease and the global NCDs agenda.
Neuen BL, Chadban SJ, Demaio AR, Johnson DW, Perkovic V. Neuen BL, et al. BMJ Glob Health. 2017 Jul 6;2(2):e000380. doi: 10.1136/bmjgh-2017-000380. eCollection 2017. BMJ Glob Health. 2017. PMID: 29225940 Free PMC article. No abstract available.
Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: A systematic review and meta-analysis.
Toyama T, Neuen BL, Jun M, Ohkuma T, Neal B, Jardine MJ, Heerspink HL, Wong MG, Ninomiya T, Wada T, Perkovic V. Toyama T, et al. Among authors: neuen bl. Diabetes Obes Metab. 2019 May;21(5):1237-1250. doi: 10.1111/dom.13648. Epub 2019 Mar 4. Diabetes Obes Metab. 2019. PMID: 30697905 Free article.
Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease: A Systematic Review and Meta-analysis.
Ha JT, Neuen BL, Cheng LP, Jun M, Toyama T, Gallagher MP, Jardine MJ, Sood MM, Garg AX, Palmer SC, Mark PB, Wheeler DC, Jha V, Freedman B, Johnson DW, Perkovic V, Badve SV. Ha JT, et al. Among authors: neuen bl. Ann Intern Med. 2019 Aug 6;171(3):181-189. doi: 10.7326/M19-0087. Epub 2019 Jul 16. Ann Intern Med. 2019. PMID: 31307056 Free article.
136 results